Prilenia Therapeutics is planning to file its Huntington’s disease drug pridopidine in the EU shortly, after mixed results in a phase 3 trial.

The iris part of the eyes lacks melanin, and they look blue because of how light is reflected. Having blue eyes may have advantages, such as a lower risk of developing cataracts; Blue eyes also may ...